Masimo said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after ...

Former Masimo CEO Joe Kiani may have won the war against Apple, but he has resigned after losing a fight with a hedge fund.

Medical tech company Masimo ( MASI) had some significant C-suite news to report on Wednesday, and investors clearly welcomed ...

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund ...

In what could become a new twist in the ongoing patent dispute over the Apple Watch’s Blood Oxygen sensor, the CEO of Masimo, ...

Masimo (NASDAQ:MASI) rose 3% after activist investor Politan Capital Management won two board seats after a bitter proxy ...

Masimo CEO Joe Kiani may have waged and won a patent dispute against Apple over its blood oxygen sensor, he has stepped down ...

Masimo stock is up as the company announces leadership changes, reiterates strong financial guidance, and expects Q3 revenue ...

Masimo Corporation's stock has underperformed, with shares down 6% versus SPY's 15% increase. Read why I remain neutral on ...

Essentially, Masimo looks set to lay all the foundational groundwork for biosensing in the next generation of Wear OS devices ...

Wells Fargo analyst Vik Chopra maintained a Buy rating on Masimo (MASI – Research Report) yesterday and set a price target of $160.00.

Masimo today confirmed the resignation of founder and CEO Joe Kiani after last week's shareholder vote ousted him as board ...